Caroline Johnston

发表

The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data

Thomas E. Nichols, Benjamin S. Aribisala, Marisa O. Hollinshead, 2014, Brain Imaging and Behavior.

Identification of Adverse Drug Events from Free Text Electronic Patient Records and Information in a Large Mental Health Case Register

Zina M. Ibrahim, R. Dobson, Caroline Johnston, 2015, PloS one.

Genetic Risk as a Marker of Amyloid-β and Tau Burden in Cerebrospinal Fluid

R. Dobson, S. Newhouse, P. Visser, 2016, Journal of Alzheimer's disease : JAD.

No Evidence to Suggest that the Use of Acetylcholinesterase Inhibitors Confounds the Results of Two Blood-Based Biomarker Studies in Alzheimer's Disease.

D. Geschwind, S. Newhouse, H. Soininen, 2015, Journal of Alzheimer's disease : JAD.

Heterogeneity of cognitive decline in dementia: a failed attempt to take into account variable time-zero severity

C. Wallace, Caroline Johnston, Steven J Kiddle, 2016, bioRxiv.

Negative symptoms in schizophrenia: a study in a large clinical sample of patients using a novel automated method

Angus Roberts, Genevieve Gorrell, Rashmi Patel, 2015, BMJ Open.

The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data

Thomas E. Nichols, Benjamin S. Aribisala, Marisa O. Hollinshead, 2014, Brain Imaging and Behavior.

Repressor Element 1 Silencing Transcription Factor Couples Loss of Pluripotency with Neural Induction and Neural Differentiation

L. Stanton, Caroline Johnston, A. Bithell, 2012, Stem cells.

Dysregulation of REST‐regulated coding and non‐coding RNAs in a cellular model of Huntington's disease

L. Stanton, Caroline Johnston, A. Bithell, 2013, Journal of neurochemistry.

The Neurogenic Potential of Astrocytes Is Regulated by Inflammatory Signals

L. Stanton, Jyaysi Desai, Caroline Johnston, 2015, Molecular Neurobiology.

Plasma Based Markers of [11C] PiB-PET Brain Amyloid Burden

Magda Tsolaki, Bruno Vellas, Andrew Simmons, 2012, PloS one.

Alzheimer's disease biomarker discovery using SOMAscan multiplexed protein technology

Magda Tsolaki, Bruno Vellas, Andrew Simmons, 2014, Alzheimer's & Dementia.

Candidate blood proteome markers of Alzheimer's disease onset and progression: a systematic review and replication study.

Magda Tsolaki, Bruno Vellas, Andrew Simmons, 2013, Journal of Alzheimer's disease : JAD.

A blood gene expression marker of early Alzheimer's disease.

Magda Tsolaki, Richard Dobson, Bruno Vellas, 2013, Journal of Alzheimer's disease : JAD.

A Pathway Based Classification Method for Analyzing Gene Expression for Alzheimer’s Disease Diagnosis

Magda Tsolaki, Bruno Vellas, Hilkka Soininen, 2015, Journal of Alzheimer's disease : JAD.

Trajectories of dementia-related cognitive decline in a large mental health records derived patient cohort

R. Dobson, S. Newhouse, R. Stewart, 2017, PloS one.

An epigenetic signature of developmental potential in neural stem cells and early neurons

L. Stanton, Caroline Johnston, A. Bithell, 2013, Stem cells.

Candidate blood proteome markers of Alzheimer's disease onset and progression: A systematic review and replication study

Magda Tsolaki, Bruno Vellas, Eric Westman, 2013, Alzheimer's & Dementia.

The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data

Thomas E. Nichols, Benjamin S. Aribisala, Marisa O. Hollinshead, 2014, Brain Imaging and Behavior.

Does genetic risk help to predict amyloid burden in a non-demented population? A Bayesian approach

R. Dobson, S. Newhouse, P. Visser, 2017, bioRxiv.

The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data

Thomas E. Nichols, Benjamin S. Aribisala, Marisa O. Hollinshead, 2014, Brain Imaging and Behavior.

The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data

Thomas E. Nichols, Rita Z. Goldstein, Benjamin S. Aribisala, 2014, Brain Imaging and Behavior.